Research & Innovation
VCU Massey researchers were recently awarded a $2.5 million R01 grant from the National Cancer Institute. The five-year grant will allow Massey to evaluate the efficacy of TROP2 targeted antibody-drug conjugates (ADCs) to further enhance therapeutic benefits in both breast and pancreatic cancer care...
Research & Innovation
Virginia Commonwealth University has announced seven recipients—including two physician-scientists with VCU Massey Comprehensive Cancer Center—of the annual Distinguished Faculty Awards, which recognize achievement in teaching, scholarship, service and overall excellence. ...
Research & Innovation
More than a third of women receiving chemotherapy for breast cancer experience significant fatigue two years after starting their treatment, a side effect that can reduce their quality of life. ...
.jpg)
Clinical Care
Jack Melson, M.D., a medical oncologist at VCU Massey who specializes in the treatment of prostate cancer, discusses the constantly evolving prostate cancer treatment landscape and how he acts as a driving force to the field. ...
Treatments in clinical trials may be more effective or have fewer side effects than the treatments that are currently available. With more than 200 studies for multiple types of cancers and cancer prevention, Massey supports a wide array of clinical trials.
Massey supports hundreds of top cancer specialists serving the needs of our patients. Massey’s medical team provides a wealth of expertise in cancer diagnosis, treatment, prevention and symptom management.
Massey is proud to partner with OncLive to provide interviews and videos from thought leaders and cutting edge articles and resources on cancer.